Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Submitted by
admin
on December 8, 2012 - 11:23am
Source:
Yahoo/PR Newswire
News Tags:
Halozyme
Roche
rituxumab
MabThera
Headline:
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Do Not Allow Advertisers to Use My Personal information